Top compounds associated with response to TRPV5


Feature Type Standardized
Nominal ANOVA
mRNA SNX-2112:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.013 0.7
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.012 0.7
mRNA SGC0946 GDSC1000 pan-cancer AAC -0.015 0.7
mRNA tivantinib CTRPv2 pan-cancer AAC 0.018 0.7
mRNA STF-31 CTRPv2 pan-cancer AAC 0.014 0.7
mRNA NG-25 GDSC1000 pan-cancer AAC 0.012 0.7
mRNA lenalidomide FIMM pan-cancer AAC 0.066 0.7
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.014 0.7
mRNA Compound 7d-cis CTRPv2 pan-cancer AAC 0.015 0.7
mRNA NVP-BEZ235 GDSC1000 pan-cancer AAC -0.014 0.7
Download CSV